High resolution coronary CT angiography provides better results among patients at high risk for CAD than does standard resolution coronary angiography.
High resolution (HR) coronary CT angiography could be a useful tool in assessing patients at high risk for coronary artery disease (CAD), according to a study published in the journal Radiology.
Researchers from Italy performed a randomized study of 184 patients who were at high risk for CAD to evaluate the image quality, evaluability, diagnostic accuracy and radiation exposure of HR coronary CT angiography, compared with standard spatial resolution (SR). All patients underwent invasive coronary angiography (ICA) within seven days of undergoing SR coronary CT angiography (91 patients) or HR coronary CT angiography (93).
The results showed that there were advantages from the HR coronary CT angiographies compared with the SR coronary CT angiographies:
Higher specificity and accuracy were also seen in patient based analysis: HR coronary CT angiography specificity of 91 percent, compared with SR at 46 percent, and HR coronary CT angiography accuracy of 98 percent, compared with SR at 92 percent.
The authors concluded that these findings suggest “a potential use for this technology in patients at high risk for CAD.”
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.